---
figid: PMC9499417__ijms-23-10412-g003
pmcid: PMC9499417
image_filename: ijms-23-10412-g003.jpg
figure_link: /pmc/articles/PMC9499417/figure/ijms-23-10412-f003/
number: Figure 3
figure_title: ''
caption: Application of IL-7 and IL-7R in cancer immunotherapy. (A) Recombinant IL-7
  administration. (B) Combination use of IL-7. (C) CAR-T and TCR T cell expressed
  IL-7. (D) CAR-T expressing engineered IL-7R or C7R. (E) CTL expressed engineered
  IL-7R. (F) Anti-IL-7R monoclonal antibodies. (G) IL-7R pathway signaling inhibitors.
article_title: The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
citation: Chunli Wang, et al. Int J Mol Sci. 2022 Sep;23(18):10412.
year: '2022'

doi: 10.3390/ijms231810412
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- IL-7
- IL-7R signal
- cancer
- immunotherapy

---
